A. D. Degli Antoni

A Reduction Grade of Lipodystrophy and Limited Side Effects after HAART Regimen with Raltegravir, Lamivudine, Darunavir and Ritonavir in an HIV-1 Infected Patient after Six Years of Antiretroviral Therapy.

A. Giacometti, V. Fragola, L. Weimer, 2015, The West Indian medical journal.

Hepatitis C virus viremia following clinical resolution of acute hepatitis C.

C. Ferrari, G. Pizzocolo, T. Giuberti, 1994, Journal of hepatology.

Combination of a drug targeting the cell with a drug targeting the virus controls human immunodeficiency virus type 1 resistance.

J. Lisziewicz, H. Jessen, F. Lori, 1997, AIDS research and human retroviruses.

Long-term follow-up of anti-hepatitis C virus antibodies in patients with acute nonA nonB hepatitis and different outcome of liver disease.

C. Ferrari, T. Giuberti, S. Marchelli, 2008, Liver.

Long-term efficacy of dolutegravir in treatment-experienced subjects failing therapy with HIV-1 integrase strand inhibitor-resistant virus

A. Lazzarin, L. Calza, V. Vullo, 2018, The Journal of antimicrobial chemotherapy.

A reduced grade of liver fibro-steatosis after raltegravir, maraviroc and fosamprenavir in an HIV/HCV co-infected patient with chronic hepatitis, cardiomyopathy, intolerance to nelfinavir and a marked increase of serum creatine phosphokinase levels probably related to integrase inhibitor use.

R. Manfredi, V. Fragola, L. Weimer, 2012, The West Indian medical journal.